Key account manager for several projects with responsibility for managing drug development activities and regulatory affairs milestones, as well as for coordinating vendor relationships on behalf of our clients. Experience in new chemical entities and new product formulations, biologics and biosimilars, vaccines, and product due diligence support. Design and implement project management tools to support projects requiring complex program management. YES Group, LLC became a US division of PharmaLex in 2016.

Responsible for managing client regulatory affairs activities, including IND/NDA/BLA preparation and submissions, FDA correspondence and meetings, and regulatory intelligence. Led creation and maintenance of drug development plans and provided project management support of development milestones. Swiftwater Group has become YES Group, the US division of YES Pharma Services GmbH in January 2014.

Drug Development Consulting to the Life Sciences Industry: Full range of services from lead compound to NDA (Nonclinical, Clinical, Regulatory, Quality Assurance).

Project manager for Penn Biotechnology Group.Developed immunotargeted drug delivery strategies to the tumor vasculature of lung cancer.